MedCloud Minute
The MedCloud Minute blog is researched, fact-checked, edited and updated by the editors of MedCloudInsider.com, with writing assistance from AI. To submit your company's press release for consideration, contact [email protected].
Lunit, an AI for cancer diagnostics provider and Labcorp, an innovative laboratory service provider, have announced a strategic collaboration to expand AI-powered digital pathology research, combining Labcorp’s large-scale tissue datasets with Lunit’s AI models for slide interpretation. The partnership will focus on improving biomarker discovery, refining diagnostic accuracy and supporting translational research in oncology. Lunit’s algorithms will be applied to Labcorp’s scanned pathology slides to analyze tumor microenvironments, quantify biomarkers and identify patterns that may guide treatment selection. The companies say the work will support both early-stage research and future clinical study design.
More
Posted by MedCloudInsider Editors on 11/17/20250 comments
Leucid Bio, a biotechnology company dedicated to the development of cell therapies, has shared an update from its ongoing Phase I/IIa AERIAL clinical trial evaluating LEU011, a Lateral CAR-T therapy targeting NKG2D ligands in advanced solid tumors. Interim results show sustained partial responses and evidence of immune persistence in patients with recurrent or metastatic head and neck squamous cell carcinoma. The treatment demonstrated a manageable safety profile with no new dose-limiting toxicities.
More
Posted by MedCloudInsider Editors on 11/10/20250 comments
Co-Diagnostics (Co-Dx), a molecular diagnosis company, announced plans to integrate its proprietary artificial intelligence algorithms into the Co-Dx Primer AI Platform, designed to accelerate PCR diagnostics. The AI component will analyze genomic data to identify optimal primer and probe sequences, reducing design time and enhancing specificity. The integration aims to support diagnostic applications in infectious diseases, oncology and other molecular testing markets.
More
Posted by MedCloudInsider Editors on 11/04/20250 comments
Bio-Techne, a global provider of life science tools and diagnostic products along with Nucleai, have announced an AI-powered spatial biology workflow designed to accelerate predictive biomarker discovery in melanoma research. The integrated solution uses AI and biotechnology for effective treatment options personalized to the patient's needs. Early results indicate improved accuracy in identifying biomarkers linked to patient response to immunotherapy.
More
Posted by MedCloudInsider Editors on 11/04/20250 comments
AIxMed dedicated to transforming cancer diagnosis and monitoring, together with PathNet, a digital pathology laboratory, has formed a strategic partnership to deploy an AI-powered urine cytology workflow designed to enhance early detection of bladder cancer. The system integrates AIxMed’s AIxURO™ technology with PathNet’s digital pathology network, allowing for automated cytology slide review and classification. The collaboration aims to reduce diagnostic variability, improve turnaround times and support hospitals transitioning from manual to AI-augmented pathology.
More
Posted by MedCloudInsider Editors on 11/04/20250 comments
Labviva, a leading AI-powered source-to-pay provider for life sciences, has launched its Smart Suppliers of the Future program to accelerate digital transformation in life sciences procurement. The initiative enables suppliers to digitalize their offerings and expand their reach through Labviva's supplier network. The move expands Labviva’s marketplace to over 15 million products from 18,000 manufacturers, representing 90 percent of life sciences suppliers across the U.S. and Europe.
More
Posted by MedCloudInsider Editors on 10/27/20250 comments
Harvard Health Publishing (HHP), part of Harvard Medical School, has licensed its library of consumer health content to Microsoft to train Copilot, the company’s AI assistant. The data includes articles on disease prevention, nutrition and wellness, all reviewed by Harvard scientists and researchers. The goal is to enhance Copilot’s accuracy when responding to healthcare-related questions. Microsoft confirmed that it paid for the license.
More
Posted by MedCloudInsider Editors on 10/21/20250 comments
dQ&A focuses its research efforts on diabetes to produce a unique take on treatment plans. They have released a beta version of their AI Insights Platform, designed to give healthcare companies, researchers and policymakers faster access to data on the diabetes market.
Posted by MedCloudInsider Editors on 10/17/20250 comments
Microsoft has expanded Dragon Copilot, its ambient AI assistant for healthcare, to include the first commercially available version designed for nursing workflows. The update allows secure integration of partner-built AI applications and agents directly within Dragon Copilot, enabling clinicians to access tools for documentation, decision support and revenue cycle automation without leaving their workflow.
More
Posted by MedCloudInsider Editors on 10/17/20250 comments
Google has reported that its Gemma AI model contributed to the discovery of a new pathway that could inform cancer drug development. Using Gemma’s generative and predictive capabilities, researchers identified a novel interaction between protein signaling networks implicated in tumor growth. The findings mark one of the first demonstrations of foundation models accelerating early-stage biomedical discovery.
The breakthrough underscores AI’s expanding role in molecular biology. While in its early stages, this tool can mark the mark of powerful, experimentally validated leads for developing new combination therapies that use a combination method for more robust results. The C2S-Scale 27B model is available to the research community with a scientific preprint, the code and the actual model available online.
Posted by MedCloudInsider Editors on 10/15/20250 comments
Nobles Medical Technology 2, a provider of cardiovascular closure solutions, announced it received FDA approval to resume its NobleStitch EL clinical trial for patent foramen ovale (PFO) closure. The minimally invasive device uses a suture-only method to close the small opening between the heart’s upper chambers, offering a potential alternative to metal implants. The company paused enrollment earlier this year following requests for additional safety and performance data, which it says have now been addressed.
More
Posted by MedCloudInsider Editors on 10/07/20250 comments
ZEISS, one of the leading medical technology companies listed on the MDAX and TecDAX of the German stock exchange, expanded its ophthalmic portfolio with new surgical instruments and digital workflow capabilities aimed at improving efficiency and visualization in vitreoretinal surgery. The updates enhance integration between DORC devices and ZEISS’s digital surgery platforms, allowing real-time data capture and imaging within a connected ecosystem. The company said the expansion supports improved surgical precision and workflow standardization across operating rooms.
More
Posted by MedCloudInsider Editors on 10/07/20250 comments